IP Library › Granted Patent US 12,725,771
Granted Patent B2
US 12,725,771 · App. 18/569,578 · Granted Sep 1, 2026

Artificial cell for single-cell mass spectrometry (SCMS) measurement and preparation method thereof

Inventors: Siyuan Tan (Beijing, CN); Xiaoyun Gong (Beijing, CN); Xinchi Yin (Beijing, CN); Zhichao Xue (Beijing, CN); Xinhua Dai (Beijing, CN); Xiang Fang (Beijing, CN)
Assignee: NATIONAL INSTITUTE OF METROLOGY, CHINA
H01J49/0409
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,725,771
App. No.
18/569,578
Granted
Sep 1, 2026
Kind
B2
Abstract

The present disclosure provides an artificial cell for single-cell mass spectrometry (SCMS) measurement and a preparation method thereof. In the present disclosure, the artificial cell includes an internal aqueous phase, an intermediate oil phase, and an external aqueous phase; where the internal aqueous phase includes polyethylene glycol (PEG) and a polyvinyl alcohol (PVA) aqueous solution, and the intermediate oil phase includes a chloroform-hexane mixture of L-α-phosphatidylcholine; and the external aqueous phase includes PVA and an F-68 aqueous solution. Compared with natural cell samples, new artificial single cells based on microfluidic self-assembly provided by the present disclosure have better uniformity, stability, and controllability. The artificial cell can effectively avoid significant measurement differences between individual single-cell samples, and effectively solve the problem of difficulty in stably preserving biological samples.

Claims (12)

1 . An artificial cell for single-cell mass spectrometry (SCMS) measurement, comprising an internal aqueous phase, an intermediate oil phase, and an external aqueous phase; wherein the internal aqueous phase comprises polyethylene glycol (PEG) and a polyvinyl alcohol (PVA) aqueous solution, and the intermediate oil phase comprises a chloroform-hexane mixture of L-α-phosphatidylcholine; and the external aqueous phase comprises PVA and an F-68 aqueous solution.

2 . A preparation method of the artificial cell according to claim 1 , comprising the following steps:

S1, building a microfluidic platform for artificial cell preparation:

the microfluidic platform is a three-phase channel, comprising an internal aqueous phase channel, an oil phase channel, and an external aqueous phase channel; a size and a structure of the artificial cell, a speed of preparation, and a microstructure of the artificial cell are regulated by controlling a width, a flow rate, and a compound composition of the channels; and

S2, preparing a double-emulsion liposome-derived artificial cell based on microfluidic self-assembly:

substances are added into the three-phase channel and emulsion droplets are squeezed out through an aqueous solution to form a primary vesicle structure of an oil-water two-phase structure; and the primary vesicle structure automatically forms the artificial cell; wherein

in step S2, the PEG and the PVA aqueous solution are added into the internal aqueous phase channel;

the chloroform-hexane mixture of the L-α-phosphatidylcholine is added into the oil phase channel; and

the PVA and the F-68 aqueous solution are added into the external aqueous phase channel.

3 . The preparation method of the artificial cell according to claim 2 , wherein the internal aqueous phase channel is an intermediate channel; the oil phase channel is divided into two sub-channels located on two sides of the internal aqueous phase channel; and the external aqueous phase channel is divided into two sub-channels outside the internal aqueous phase channel.

4 . The preparation method of the artificial cell according to claim 2 , wherein an organic dye or a fluorescent dye is further added into the internal aqueous phase channel in step S2.

5 . The preparation method of the artificial cell according to claim 2 , wherein in step S2, target compounds of different contents are added into the internal aqueous phase channel; and the target compound comprises adenosine triphosphate (ATP).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2023
From: TAN, SIYUAN; GONG, XIAOYUN; YIN, XINCHI; XUE, ZHICHAO; DAI, XINHUA; FANG, XIANG
To: NATIONAL INSTITUTE OF METROLOGY, CHINA
Reel/Frame 065850/0419 →
Priority Claims (1)
CN 202310272610.6 · Mar 20, 2023 · national
Continuity (1)
Related Publication 20240420940A1 · Dec 19, 2024
References Cited (2)
US 10032615B2 · Agar · 2018 [cited by examiner]
US 20110124520A1 · Love · 2011 [cited by examiner]